Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-229.81M
↓ 175% below average
Average (8y)
$-83.53M
Historical baseline
Range
High:$-5.66M
Low:$-229.81M
CAGR
+58.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-229.81M | -34.4% |
| 2023 | $-171.00M | -46.3% |
| 2022 | $-116.86M | -31.3% |
| 2021 | $-89.02M | -43.1% |
| 2020 | $-62.21M | -32.7% |
| 2019 | $-46.87M | -128.4% |
| 2018 | $-20.52M | -109.7% |
| 2017 | $-9.78M | -72.9% |
| 2016 | $-5.66M | - |